Extended Data Figure 5: Body weight of control and of adipose-specific Cdk5-KO mice maintained on a high-fat diet after treatment with PD0325901.
From: An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
Treatment similar to that in Fig. 4a–c. The body weights are not significantly different by ANOVA. Error bars indicate s.e.m.
